Ardent Health, Inc. (ARDT) intrinsic value & 10-year financials
Ardent Health, Inc. (ARDT) has no Graham intrinsic value right now because the formula needs positive earnings. Over the last 5 fiscal years revenue grew 7.2% a year to $6.3B, with an average return on invested capital of 11.1%.
- Graham intrinsic value
- —
- Share price (Oct 17, 2026)
- $11.95
- Market cap
- $1.7B
- Revenue (FY2025)
- $6.3B
- Revenue growth (5-yr CAGR)
- 7.2%
- ROIC (10-yr avg)
- 11.1%
- Free cash flow (FY2025)
- —
ARDT 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $6.3B | $135.8M | $0.96 | — | — | 8.2% |
| FY2024 | $6.0B | $210.3M | $1.58 | — | — | 13.7% |
| FY2023 | $5.4B | $53.9M | $0.43 | — | — | 3.8% |
| FY2022 | $5.1B | $188.9M | $1.50 | — | — | 18.7% |
| FY2021 | — | — | — | — | — | — |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
Ardent Health, Inc. revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.
Ardent Health, Inc. returns on capital have been average, hovering around 11.1% ROIC over the decade.
Ardent Health, Inc. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, Ardent Health, Inc. is modeled at -13.8% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $-15.85 per share.